Global Markets
thumbnail
Facilities & CapacityVaccine maker Bavarian Nordic readies production for mpox riskVaccine maker Bavarian Nordic readies production for mpox risk
Amid the current mpox outbreak, Bavarian Nordic says it will have the capacity to manufacture 10 million doses of its vaccine by the end of 2025.
Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ member. Yes, it's completely free.